- This event has passed.
Circulating Tumor Cells (CTCs): Understanding the biology, challenges, clinical utility and future prospects
25th March 2019 @ 10:00 am - 5:00 pm
Yenepoya Research Centre, Yenepoya (Deemed to be University) organized a guest lecture by Dr. Prashant Kumar, Faculty Scientist at Institute of “Circulating Tumor Cells (CTCs): Understanding the biology, challenges, clinical utility and future prospects” on 25.03.2019 at EMD Auditorium, 8th Floor, YMCH. All the research faculties, research scholars and clinicians from dept. of Urology and Oncology were attended the talk. Dr. Keshava Prasad addressed a welcome speech with Dr Prashant Kumar’s brief profile and his achievements during the research career. Dr Prashant Kumar discussed about the strategy for the d satge by using liquid biopsy. He briefly described the importance of CTCs in cancer care, methods for islotion and detection of the CTCs. During his talk he emphasized on the method of the CTC and numbers of CTC found in peripheral blood in different types of cancer such as breast, pancreatic, prostate, colon cancer etc. He had also discussed the challenges for CTC detection. The talk was enlightening and very successful. There was an active discussion with oncosurgeons, Dr. Jalaluddin Akbar. Dr. MujeebuRahiman, and Dr. Altaf Khan after the talk.
After the talk, he visited our center along with Mr. IOB. They trained our team to processes a blood sample for isolation of circulating tumor cells and demonstrated the detailed methodology step by step in the Center for Systems Biology and Molecular Medicine (CSBMM), Yenepoya Research Centre.
Next day (26.03.2019), Dr. Prashant Kumaralong with Dr. Prashant Kumar Modi, and Dr. Shobhaparticipated in the interaction meeting with Dr Singh, Dr. Altaf Khan and Dr. Ibrahim Nagnoorat Urology depart Dr. Prashant discussed the implementation of cancer such as prostate cancer, bladder cancer impact of these CTCs for community Dr.Keshava Prasad, Dr Dr.MujeebRahiman, Dr. Vinit Kumar department. During the interaction session, CTCs as a diagnostic and prognostic marker for various cancer, and renal cell carcinoma. He also discussed the social community-based screening of various cancer with Dr. Ibrahim Nagnoor.